Cytotoxic T lymphocytes (CTL) protect against viruses including HIV-1. To avoid viral escape mutants that thwart immunity, we chose 25 CTL epitopes defined in the context of natural infection with functional and/or structural constraints that maintain sequence conservation. By combining HLA binding predictions with knowledge concerning HLA allele frequencies, a metric estimating population protection coverage (PPC) was computed and epitope pools assembled. Strikingly, only a minority of immunocompetent HIV-1 infected individuals responds to pools with PPC >95%. In contrast, virus-naive individuals uniformly expand IFNγ producing cells and mount anti-HIV-1 cytolytic activity. This disparity suggests a vaccine design paradigm shift from infec...
A successful HIV vaccine will likely induce both humoral and cell-mediated immunity, however, the en...
Two to three years after infection, a fraction of HIV-1–infected individuals develop serologic activ...
HIV-1-specific CD8+ T cells are an important component of HIV-1 curative strategies. Viral variants ...
Background: HLA class-I alleles differ in their ability to control HIV replication through cell-medi...
Human lymphocyte antigen (HLA)-restricted CD8\(^+\) cytotoxic T lymphocytes (CTL) target and kill HI...
One of the approaches by which the scientific community is seeking to cure HIV is the use of therape...
Thesis (Ph.D.)--University of Washington, 2012The enormity of global human immunodeficiency virus ty...
Virus diversity and escape from immune responses are the biggest challenges to the development of an...
Background Fine definition of targeted CD8+ T-cell epitopes and their human leucocyte antigen (HLA)...
CD8+ Cytotoxic T-Lymphocytes (CTLs) are critical for control of viremia during Human Immunodeficienc...
Thesis (Ph.D.)--University of Washington, 2013Despite over 30 years of intensive research, the devel...
Altres ajuts: MTM/2008-06747-C02-00Altres ajuts: FIPSE/36-0737-0Altres ajuts: P01AI057005BACKGROUND:...
Objective and design: HIV-1 is known to adapt to the human immune system, leading to accumulation of...
The immune system should constitute a strong selective pressure promoting viral genetic diversity an...
Early control of HIV-1 infection is determined by a balance between the host immune response and the...
A successful HIV vaccine will likely induce both humoral and cell-mediated immunity, however, the en...
Two to three years after infection, a fraction of HIV-1–infected individuals develop serologic activ...
HIV-1-specific CD8+ T cells are an important component of HIV-1 curative strategies. Viral variants ...
Background: HLA class-I alleles differ in their ability to control HIV replication through cell-medi...
Human lymphocyte antigen (HLA)-restricted CD8\(^+\) cytotoxic T lymphocytes (CTL) target and kill HI...
One of the approaches by which the scientific community is seeking to cure HIV is the use of therape...
Thesis (Ph.D.)--University of Washington, 2012The enormity of global human immunodeficiency virus ty...
Virus diversity and escape from immune responses are the biggest challenges to the development of an...
Background Fine definition of targeted CD8+ T-cell epitopes and their human leucocyte antigen (HLA)...
CD8+ Cytotoxic T-Lymphocytes (CTLs) are critical for control of viremia during Human Immunodeficienc...
Thesis (Ph.D.)--University of Washington, 2013Despite over 30 years of intensive research, the devel...
Altres ajuts: MTM/2008-06747-C02-00Altres ajuts: FIPSE/36-0737-0Altres ajuts: P01AI057005BACKGROUND:...
Objective and design: HIV-1 is known to adapt to the human immune system, leading to accumulation of...
The immune system should constitute a strong selective pressure promoting viral genetic diversity an...
Early control of HIV-1 infection is determined by a balance between the host immune response and the...
A successful HIV vaccine will likely induce both humoral and cell-mediated immunity, however, the en...
Two to three years after infection, a fraction of HIV-1–infected individuals develop serologic activ...
HIV-1-specific CD8+ T cells are an important component of HIV-1 curative strategies. Viral variants ...